1. Home
  2. RNXT vs LEE Comparison

RNXT vs LEE Comparison

Compare RNXT & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • LEE
  • Stock Information
  • Founded
  • RNXT 2012
  • LEE 1890
  • Country
  • RNXT United States
  • LEE United States
  • Employees
  • RNXT N/A
  • LEE N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • RNXT Health Care
  • LEE Consumer Discretionary
  • Exchange
  • RNXT Nasdaq
  • LEE Nasdaq
  • Market Cap
  • RNXT 44.6M
  • LEE 52.4M
  • IPO Year
  • RNXT 2021
  • LEE N/A
  • Fundamental
  • Price
  • RNXT $1.36
  • LEE $6.30
  • Analyst Decision
  • RNXT Strong Buy
  • LEE
  • Analyst Count
  • RNXT 2
  • LEE 0
  • Target Price
  • RNXT $7.25
  • LEE N/A
  • AVG Volume (30 Days)
  • RNXT 190.7K
  • LEE 18.0K
  • Earning Date
  • RNXT 08-12-2025
  • LEE 07-31-2025
  • Dividend Yield
  • RNXT N/A
  • LEE N/A
  • EPS Growth
  • RNXT N/A
  • LEE N/A
  • EPS
  • RNXT N/A
  • LEE N/A
  • Revenue
  • RNXT $240,000.00
  • LEE $591,094,000.00
  • Revenue This Year
  • RNXT $3,186.05
  • LEE N/A
  • Revenue Next Year
  • RNXT $291.93
  • LEE N/A
  • P/E Ratio
  • RNXT N/A
  • LEE N/A
  • Revenue Growth
  • RNXT N/A
  • LEE N/A
  • 52 Week Low
  • RNXT $0.75
  • LEE $6.00
  • 52 Week High
  • RNXT $1.69
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 58.97
  • LEE 32.43
  • Support Level
  • RNXT $1.26
  • LEE $6.20
  • Resistance Level
  • RNXT $1.40
  • LEE $6.72
  • Average True Range (ATR)
  • RNXT 0.05
  • LEE 0.39
  • MACD
  • RNXT -0.01
  • LEE 0.03
  • Stochastic Oscillator
  • RNXT 48.70
  • LEE 21.00

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: